Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,056
Closed -$121K 1845
2026
Q1
$121K Hold
1,056
﹤0.01% 1209
2025
Q4
$69K Hold
1,056
﹤0.01% 1502
2025
Q3
$87K Hold
1,056
﹤0.01% 1345
2025
Q2
$70K Sell
1,056
-441
-29% -$27.5K ﹤0.01% 1426
2025
Q1
$98K Buy
1,497
+109
+8% +$7.38K ﹤0.01% 1490
2024
Q4
$106K Buy
1,388
+377
+37% +$32.6K ﹤0.01% 1514
2024
Q3
$84K Hold
1,011
﹤0.01% 1397
2024
Q2
$56K Buy
1,011
+345
+52% +$18.8K ﹤0.01% 1547
2024
Q1
$46K Buy
+666
New +$42.2K ﹤0.01% 1602

Other funds holding ACLX

KBC Group's ACLX Position: Q2 2026 in Review

KBC Group sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 1,056 shares — an estimated $121K sold.

KBC Group first reported a position in ACLX in Q1 2024 and held it in 9 quarters. The position peaked at $121K in Q1 2026. 2 funds tracked by Wall St. Rank hold ACLX as of Q2 2026.

  • KBC Group reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
  • KBC Group sold 1,056 Arcellx shares in Q2 2026, an estimated $121K.
  • KBC Group first reported a position in Arcellx in Q1 2024 and held it in 9 quarters.
  • KBC Group's Arcellx position peaked at $121K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Arcellx as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.